KRISTEN LYNCH: Open Payments
NPI 1093427734 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 29 payments from 11 companies in 2025. Trend: 2023 $297 · 2024 $518 · 2025 $676
Food & beverage: $656Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $194 |
| AstraZeneca Pharmaceuticals LP | 4 | $135 |
| Alnylam Pharmaceuticals Inc. | 3 | $83 |
| Novo Nordisk Inc | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| PFIZER INC. | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: REPATHA, AMVUTTRA, Wegovy, FARXIGA, JARDIANCE, WAINUA, Assure WCD, LOKELMA.
Industry payments across IN — which companies pay providers there.
